Concepedia

Author

Xinmin Yu

Zhejiang Cancer Hospital

Also Known As

XINMIN YU, Xin-Min Yu, Xin-min Yu, Xinmin Yu, Xin‐Min Yu, Yu Xinmin

51

Publications

520

Citations

13

H-Index

22

Concepts

All Affiliations

Zhejiang Cancer HospitalPeking UniversityPeking University Cancer HospitalHenan Cancer HospitalShandong First Medical University
XY

About

Xinmin Yu is an author at Zhejiang Cancer Hospital specializing in cancer therapeutics, radiation oncology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

5

5

251

2

Medicine

5

5

251

3

Pathology

3

3

108

4

Immunology

2

2

38

5

Molecular Medicine

1

1

31

Xinmin Yu

×

12

Publications

378

Citations

12

H-Index

YearCitations

Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population

Shenglin Ma, Yaping Xu, Qinghua Deng,

Lung Cancer

2008

130

RATIONALE 302: Randomized, phase 3 study of tislelizumab versus chemotherapy as second-line treatment for advanced unresectable/metastatic esophageal squamous cell carcinoma.

Lin Shen, Ken Kato, Sung‐Bae Kim,

Journal of Clinical Oncology

2021

52

Randomized phase III trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm).

Shun Lü, Xiaorong Dong, Hong Jian,

Journal of Clinical Oncology

2021

31

Efficacy of PD-1 monoclonal antibody SHR-1210 plus apatinib in patients with advanced nonsquamous NSCLC with wild‐type EGFR and ALK.

Caicun Zhou, Guanghui Gao, Yi Na Wang,

Journal of Clinical Oncology

2019

25

Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases

Yaping Xu, Qixun Chen, Xinmin Yu,

Oncology Letters

2012

21

Chemotherapy and prognosis in advanced thymic carcinoma patients

Zhengbo Song, Xinmin Yu, Yiping Zhang

Clinics

2015

21

A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer

Xiaojiang Sun, Qinghua Deng, Xinmin Yu,

BMC Cancer

2016

21

Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population

Wei Hong, Kai Wang, Yiping Zhang,

Journal of Zhejiang University SCIENCE B

2013

19

Efficacy and safety of icotinib in Chinese patients with advanced nonsmall cell lung cancer after failure of chemotherapy

Lan Shao, Beibei Zhang, Chunxiao He,

Chinese Medical Journal

2014

17

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, <i>EGFR</i> ‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS)

Shun Lü, Xiaorong Dong, Hong Jian,

Cancer Communications

2024

16

Page 1